When you assumed the presidency of the board of directors, you were able to indirectly obtain funds for various projects. You invested in companies that were in your investment portfolio, such as DeNova. You invest in the Sandpiper fund, and these companies are part of Sandpiper's portfolio. That means that these companies are indirectly part of your personal portfolio. I'll come back to that.
While you were president of the board of directors, there was one bioreactor development project in particular. If I understand correctly, the project was needed to ensure growth at DeNova, which is part of the Sandpiper portfolio. You submitted an application for the bioreactor project to SDTC. Based on the documents I have here, the application for funding was for $2.5 million.
The application was obviously deemed to be inadmissible, because there was a huge conflict of interest. However, Mr. Rahme, for his part, asked all his teams to make every effort to secure you funding anyway. The amount you received for this project at the Verschuren Centre was practically $11 million.
I can give you the details. Nova Scotia granted you $2.5 million in funding. The Atlantic Canada Opportunities Agency, or ACOA, whose senior advisor was Andrew Noseworthy, awarded you $2 million. NGen gave you $2.3 million, which was subsidized by Innovation, Science and Economic Development Canada. That's nearly $7 million.
In 2023, the Forestry Innovation Transition Trust, which was subsidized by the government of Nova Scotia, gave you $925,000. ACOA gave you another million dollars. Finally, the Canadian Food Innovation Network gave you $1.1 million, which was subsidized by the Strategic Innovation Fund. This fund was created by Innovation, Science and Economic Development Canada.